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Edited by Sandro SonninoAbstract Talin mediates integrin signaling by binding to inte-
grin cytoplasmic tails through its FERM domain which consists
of F1, F2 and F3 subdomains. TA205, an anti-talin monoclonal
antibody, disrupts actin stress ﬁbers and focal adhesion when
microinjected into ﬁbroblasts. Here, we showed that TA205
caused an allosteric inhibition of integrin aIIbb3 binding to the ta-
lin FERM domain and mapped the TA205 epitope to residues
131–150 in talin F1. Furthermore, binding of a talin rod frag-
ment to talin head was partially inhibited by TA205. These ﬁnd-
ings suggest that talin F1 may be important in regulation of
integrin binding and talin head–rod interaction.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Integrins are ab heterodimeric adhesion receptors that medi-
ate bidirectional inside-out and outside-in signaling [1]. Talin,
a cytoskeletal protein consisting of a globular head and a ﬂex-
ible rod domains, is a prominent component of focal adhesion
linking integrins with actin ﬁlaments [2,3]. Recently, talin–inte-
grin interaction has been implicated in inside-out signaling
processes that activate integrins to increase their ligand bind-
ing aﬃnity. Thus, overexpression of talin head fragments into
Chinese hamster ovary (CHO) cells expressing integrin aIIbb3
results in receptor activation [4,5]. Conversely, talin knock-
down by transfection of small interfering RNAs into cells
inhibits cellular activation of b1 and b3 integrins [6].
There are two integrin binding sites per talin molecule, one
in the talin head and another near the C-terminus of the talin
rod [4,7–10]. The talin head contains an 300 amino acid
FERM (band four-point-one, ezrin, radixin, and moesin) do-
main comprising of three subdomain folds (F1, F2 and F3)
that form a clover-shaped structure [3,11]. Talin F3 contains
a phosphotyrosine-binding domain that interacts with theAbbreviations: CHO, Chinese hamster ovary; FERM, band four-point-
one, ezrin, radixin, moesin; ELISA, enzyme-linked immunosorbent
assay; PCR, polymerase chain reaction; BSA, bovine serum albumin
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expressing CHO cell system, integrin activation can be
achieved by expression of talin F3 alone [5]. In contrast, talin
F2 also binds to the b3 tail with a 4-fold lower aﬃnity but can-
not activate aIIbb3. At present, the functional role of talin F1 is
not known.
TA205, an anti-talin monoclonal antibody, disrupts focal
adhesion, stress ﬁber formation and cell migration when micro-
injected into human ﬁbroblasts [12]. In this study, we showed
that TA205 causes an allosteric inhibition on integrin binding
to the talin FERM domain, providing a possible mechanism
of its inhibitory action on integrin-mediated cell function. Fur-
thermore, we mapped the TA205 epitope to talin F1, and
showed that TA205 modulates talin head–rod interaction.2. Materials and methods
2.1. Reagents
The anti-talin monoclonal antibodies TA205, TD77 and 8d4 were
purchased from Upstate (Charlottesville, VA), Research Diagnostic
Inc. (Concord, MA), and Sigma (St. Louis, MO), respectively. AP-3,
an anti-b3 monoclonal antibody, was produced as ascites ﬂuid in mice
and puriﬁed by Protein A chromatography. Streptavidin was obtained
from Sigma (St. Louis, MO). TA205, 8d4, AP-3 and streptavidin were
labeled with carrier-free Na125I (ICN Biomedicals, Inc., Irvine, CA)
using the Iodobeads iodination reagent (Pierce, Rockford, IL) to a spe-
ciﬁc activity of approximately 2 lCi/lg for antibodies and 0.5 lCi/lg
for streptavidin. Peptides corresponding to residues 131–150 of mouse
talin (RELMEEKKDEGTGTLRKDKT) or human talin (REL-
MEEKKEEITGTLRKDKT) and the biotin-b3-(716–733) peptide
were synthesized by Invitrogen (Carlsbad, CA).
2.2. Talin cDNA constructs
Generation of human talin head and rod constructs has been de-
scribed previously [8,9]. Site-directed mutation of talin head was per-
formed using the QuickChange mutagenesis kit (Stratagene, La
Jolla, CA). To create fragments of the talin FERM subdomains, poly-
merase chain reactions (PCR) were performed on the talin head con-
struct using Pfu and oligonucleotide primer pairs derived from the
human talin cDNA sequence (GenBank accession number
AF078828). The PCR products were cloned into the pET-30-a(+) vec-
tor (Novagen, EMD Biosciences, Inc., Madison, WI), and all con-
structs were veriﬁed by DNA sequencing. The amino acid residues
of the talin fragments were: F1, 88–202; F2, 200–311; F3, 303–410;
F1–F2, 88–311; F1–F2–F3, 88–410.
2.3. Protein isolation
Integrin aIIbb3 was puriﬁed from octylglucoside extracts of outdated
human platelets by RGD aﬃnity chromatography followed by gel ﬁl-
tration on a Sephacryl S-300 HR column [7]. Talin was puriﬁed from
Triton X-100 extracts of outdated human platelets as described [13],
and dialyzed into phosphate-buﬀered saline (PBS: 10 mM sodium
phosphate, pH 7.3, 0.15 M NaCl).blished by Elsevier B.V. All rights reserved.
Fig. 1. TA205 inhibits aIIbb3 binding to talin. (A) Microtiter wells
coated with puriﬁed talin (50 lg/ml, 50 ll/well) or recombinant talin
head (10 lg/ml, 50 ll/well) were incubated with TA205, mouse IgG or
vehicle buﬀer for 1 h at 22 C. After removal of unbound antibody,
puriﬁed aIIbb3 (10 lg/ml, 50 ll/well) was added and incubated for 3 h
at 37 C. Bound integrin was detected with 125I-AP-3. (B) Talin was
immunocaptured onto 8d4-coated wells as described in Section 2,
followed by incubation with 0.2 lM TA205 or IgG. Binding of aIIbb3
to immunocaptured talin was performed as described above.
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histidine-tagged proteins. Brieﬂy, cDNA constructs of talin fragments
were transformed into Escherichia coli BL21(DE3)-competent cells,
and protein expression was induced with 1 mM isopropylthio-b-D-
galactoside for 4 h at 37 C. The hexahistidine-tagged proteins were
puriﬁed by chromatography on Ni2+ resin (Novagen, EMD Biosci-
ences, Inc., Madison, WI), followed by desalting on Sephadex G-15
columns. The wild type and mutant talin head fragments, containing
the hexahistidine tag at their C-termini downstream of the endogenous
calpain cleavage at Gln433Gln434 in talin, were digested with m-calpain
(Sigma, St. Louis, MO) and the hexahistidine tags were removed by gel
ﬁltration on a Sephacryl S-100 column (16 · 60 cm). All other talin
head fragments with the hexahistidine tags fused to their N-termini
were digested with enterokinase (Novagen, EMD Biosciences, Inc.,
Madison, WI) and the histidine tags were absorbed with Ni2+ resin.
The talin-(434–2541) rod fragment was produced and puriﬁed as
described [9].
2.4. ELISA and solid-phase binding assay
Intact talin puriﬁed from platelet extracts or recombinant talin
fragments were coated onto Immulon 4 HBX microtiter strips (Ther-
mo Labsystems, Franklin, MA), followed by blocking with 3% bo-
vine serum albumin (BSA). For enzyme-linked immunosorbent
assay (ELISA), TA205 (0.5 lg/ml) was added and incubated for
2 h at 22 C. Bound TA205 was detected with horseradish peroxi-
dase-conjugated secondary antibodies using o-phenylenediamine
hydrochloride as the substrate and A450 was measured after 15–
30 min incubation at 22 C. Alternatively, binding of 125I-labeled
TA205 was performed and bound antibody was quantiﬁed by
c-counting. For solid-phase binding assay, puriﬁed aIIbb3 or biotin-
b3-(716–733) peptide was added to protein-coated wells and incu-
bated for 3 h at 37 C. After washing, bound aIIbb3 was detected
with 50 nM 125I-AP-3, and bound biotin-b3-(716–733) peptide was
detected with 0.5 lM 125I-streptavidin [8]. In the immunocapture
binding assay, microtiter wells were coated with 8d4 (40 lg/ml,
50 ll/well) and blocked with BSA. Talin (200 lg/ml, 50 ll/well) was
allowed to bind to 8d4-coated wells by overnight incubation at
4 C. Puriﬁed aIIbb3 was then added with or without TA205, and
bound receptor was detected as described above.3. Results
3.1. TA205 inhibited integrin aIIbb3 binding to talin head
TA205 disrupts integrin-mediated cellular function when
microinjected into ﬁbroblasts [12]. To test the possibility that
TA205 blocks integrin–talin interaction, we examined the ef-
fect of TA205 on aIIbb3 binding to immobilized full-length ta-
lin and the talin head domain. Fig. 1A shows that TA205, but
not an isotype-matched mouse IgG, dose-dependently inhib-
ited the binding of aIIbb3 to both talin and the talin head frag-
ment. Additionally, 8d4 and TD77, two other anti-talin
monoclonal antibodies that react with the talin rod domain
[12,14], had no eﬀect on aIIbb3 binding to full-length talin (re-
sults not shown). At high concentrations, TA205 inhibited
aIIbb3 binding to full-length talin by 50%, whereas complete
inhibition of aIIbb3 binding to the talin head was observed. Be-
cause coating of talin onto microtiter wells may change its con-
formation, we examined the inhibitory eﬀect of TA205 on
aIIbb3 binding to talin immunocaptured by 8d4. Again,
Fig. 1B shows that TA205, but not mouse IgG, inhibited aIIbb3
binding to 8d4-captured full-length talin by 50%. Thus, re-
sults of these inhibition studies are consistent with the observa-
tions that two integrin binding sites are present per talin
molecule, one in the talin head and another in the talin rod.
TA205 blocks integrin binding to the high aﬃnity site in the
talin head but not to the low aﬃnity site in the talin rod. Fur-
thermore, TA205 is likely to inhibit stress ﬁber and focal adhe-sion formation by blocking integrin interaction with the talin
head domain.
Next, we determined whether TA205 acts as an allosteric or
competitive inhibitor of aIIbb3 binding to the talin head. As
an initial approach, we performed aIIbb3 binding isotherms
to immobilized talin head in the presence and absence of
10 nM TA205 which caused sub-maximal inhibition. As
shown in Fig. 2A, TA205 had no eﬀect on the apparent Kd
value of aIIbb3-talin head interaction, which was estimated
by half saturation binding to be 12 nM input aIIbb3.
Rather, in the presence of TA205, maximal aIIbb3 binding
to the talin head was signiﬁcantly decreased. These results
indicate a non-competitive mode of inhibition. To substanti-
ate these observations, we examined the inhibitory eﬀect of
TA205 over a 5-fold diﬀerence of aIIbb3 concentration. If
TA205 behaves as an allosteric inhibitor, the inhibitor con-
centration required for half-maximal inhibition would be un-
changed [15]. Indeed, Fig. 2B shows that the concentration of
TA205 required for half-maximal inhibition (20 nM) was
not signiﬁcantly diﬀerent at high or low aIIbb3 concentration.
Together, these results suggest that TA205 causes an alloste-
ric rather than competitive inhibition on aIIbb3 binding to the
talin head.
The juxtaposing membrane-proximal helices of integrin aIIb
and b3 tails interact with each other to lock the receptor in an
inactive state [16,17]. The talin head binds to the NPLY re-
verse turn and the membrane-proximal helix (residue 716–
733) of the b3 tail [8,11,16]. It has been suggested that talin
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Fig. 2. Allosteric inhibition of aIIbb3–talin interaction by TA205. (A)
Various concentrations of aIIbb3 were added to wells coated with
recombinant talin head in the presence and absence of 10 nM TA205.
(B) Various concentrations of TA205 were added with 25 or 125 nM
aIIbb3 to talin head-coated wells. Binding of aIIbb3 proceeded as
described in Fig. 1.
Fig. 4. Immunoblot analysis of talin FERM fragments reactive with
TA205. Puriﬁed recombinant talin FERM subdomain fragments were
separated on 15% polyacrylamide gels. The resolved proteins were
detected by: (A) coomassie blue staining or (B) immunoblotting with
TA205. The lanes contained: (1) F1–F2; (2) F1–F2–F3; (3) F1; (4) F2;
(5) F3.
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separation resulting in receptor activation [18]. Since TA205
inhibits aIIbb3–talin head interaction, we tested its eﬀect on0
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Fig. 3. TA205 inhibits interaction of the membrane-proximal region
of the b3 tail with the talin head. Microtiter wells coated with
recombinant talin head were pre-incubated with the indicated antibody
or vehicle buﬀer. Biotin-b3-(716–733) peptide (0.8 mM) was allowed to
bind for 3 h at 37 C, and bound peptide was detected with 0.5 lM
125I-streptavidin.the binding of a biotin-b3-(716–733) peptide to the talin head.
As shown in Fig. 3, TA205 also inhibited the binding of the b3
membrane-proximal peptide to talin head, whereas mouse IgG
had no eﬀect.
3.2. Epitope-mapping of TA205 in the talin FERM domain
To gain further insight into TA205 inhibition of talin–inte-
grin interaction, we performed experiments to map the
TA205 epitope in the talin FERM domain. Initially, we tested
the ability of TA205 to immunoblot talin head fragments.
Fig. 4A shows that recombinant talin fragments migrated at
the expected molecular masses on sodium dodecyl sulfate–
polyacrylamide gel electrophoresis. On immunoblot, TA205
reacted with talin F1–F2 (lane 1), F1–F2–F3 (lane 2), and
F1 (lane 3), but not with F2 (lane 4) and F3 (lane 5)
(Fig. 4B). These results indicate that the TA205 epitope resides
within talin F1.
It has been reported that TA205 immunoblots human and
chicken talin, but not the mouse isoform [12]. Within talin
F1, there are two amino acid changes (i.e., E139D and I141G)
from human to mouse sequence [8]. Therefore, we synthesized
peptides corresponding to residues 131–150 of human and
mouse talin, and tested their ability to block TA205 binding
to talin head. As expected, the human talin-(131–150) peptide
eﬀectively blocked TA205 binding to talin head whereas the
mouse talin-(131–150) peptide had no eﬀect (Fig. 5A). These
ﬁndings indicate that the TA205 epitope is present within the
human talin-(131–150) sequence. We then performed site-di-
rected mutagenesis on the human talin head and examined
the eﬀect of E139D or I141G single substitution on TA205 reac-
tivity by immunoblot analysis. Fig. 5B shows that TA205
immunoblotted wild type and the E139D mutant of talin head.
In contrast, the I141G mutant failed to bind TA205. Thus, a
single I141G substitution in the human talin head abolished
its ability to bind TA205.3.3. Talin head–rod interaction and its eﬀect on TA205 binding
to talin
In other FERM family proteins, an intramolecular interac-
tion between their head and tail domains regulate the expo-
sure of their binding sites for cell surface receptors and
actin [19,20]. However, direct interaction of the talin head
and rod domains has not been demonstrated to date. Thus,
Fig. 5. Identiﬁcation of the TA205 epitope in talin. (A) TA205 (0.5 lg/
ml), pre-incubated with or without mouse or human talin-(131–150)
peptide (1 mM), were added to wells coated with talin head. Following
incubation for 1 h at 37 C, bound antibody was detected by an ELISA
(see Section 2). (B) Wild type (WT) and the E139D or I141G mutant
talin head were electrophoresed on 10% polyacrylamide gels and
detected by Coomassie blue staining or immunoblotting with TA205.
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Fig. 6. Eﬀect of TA205 on talin head–rod interaction. (A) Microtiter
wells were coated with recombinant talin head or BSA. Recombinant
talin-(434–2541) rod fragment (0.25 lM) was added with 0.2 lM
TA205, IgG or vehicle buﬀer and allowed to bind to immobilized talin
head for 3 h at 37 C. Bound talin rod fragment was detected with 125I-
8d4. (B) Talin head-coated wells were preincubated with various
concentrations of the talin rod fragment. Binding of 125I-TA205
(5 nM) proceeded for 1 h at 22 C.
2030 B. Xing et al. / FEBS Letters 580 (2006) 2027–2032we performed solid phase binding studies to examine whether
a soluble talin rod fragment binds to immobilized talin head,
and whether such interaction aﬀects TA205 binding. Fig. 6A
shows that the talin-(434–2541) fragment corresponding the
entire talin rod binds to talin head-coated microtiter wells
but not to control wells coated with BSA. Furthermore, we
consistently observed that pre-incubation of talin head-coated
wells with a saturating concentration of TA205 (0.2 lM) sig-
niﬁcantly inhibited talin rod binding by 30% whereas mouse
IgG had no eﬀect. Nevertheless, complete inhibition was not
observed with TA205 even though an anti-talin head poly-
clonal antibody completely blocked talin head–rod interac-
tion (results not shown). It should be noted that the
concentration of TA205 used in these experiments caused
complete inhibition of aIIbb3 binding to the talin head (see
Fig. 1A). We next examined whether the talin rod fragment
blocks TA205 binding to the talin head. As shown in
Fig. 6B, pre-incubation of talin head-coated wells with the ta-
lin rod fragment caused a dose-dependent inhibition of
TA205 binding. Interestingly, similar to the inhibitory eﬀect
of TA205 on talin head–rod binding, only partial inhibition
of 36% was observed at the highest concentration of the ta-
lin rod fragment tested.4. Discussion
Interaction of talin with integrin cytoplasmic domains plays
a central role in integrin inside-out and outside-in signaling. In
the present study, we showed TA205, a function-blocking anti-
talin monoclonal antibody [12], inhibits integrin aIIbb3 binding
to the talin head domain. In biochemical and mutational stud-
ies, we mapped the TA205 epitope to residues 131–150 in the
human talin F1 sequence with Ile141 being a critical residue
for antibody binding. While the crystal structure of talin F1
has not been resolved, both F1 domains of radixin and moesin
have a typical ubiquitin fold consisting of a long a-helix
packed against a 5-stranded mixed b-sheet [19,20]. If talin F1
folds similarly as these ERM proteins, the TA205 epitope
would reside near the N-terminal region of the a-helix accord-
ing to their sequence alignment [5]. Inasmuch as the integrin
binding site(s) is present in talin F2 and F3, but not in talin
F1 [5], the ability of TA205 to inhibit aIIbb3 binding to the talin
head indicates that its epitope is not directly involved in inte-
grin binding. Indeed, we found that TA205 does not compete
directly with aIIbb3 for binding to the talin head, but instead
causes an allosteric inhibitory eﬀect which may be due to con-
formational changes of the talin FERM domain upon anti-
body binding.
Integrin–talin interaction has been implicated as a ﬁnal step
of inside-out signaling responses that lead to integrin activa-
tion [5,6]. Increasing evidence suggest that integrins are main-
B. Xing et al. / FEBS Letters 580 (2006) 2027–2032 2031tained in the low aﬃnity inactive state by interaction of the a
and b transmembrane helices extending through the mem-
brane-proximal cytoplasmic regions [16,17,21]. Talin binding
to the b3 tail, particularly to its membrane-proximal a-helix,
is thought to disrupt intersubunit interaction thereby resulting
in integrin activation [18]. Since TA205 blocks integrin binding
to the talin head, it may aﬀect cellular function by inhibition of
talin-induced integrin activation. In support of this postula-
tion, we found that TA205 also inhibits the binding of a pep-
tide corresponding to the b3-(716–733) membrane-proximal
sequence to the talin head. It is noteworthy that the mem-
brane-proximal region of the b3 tail also interacts with talin
F3 [22], but not with talin F1 where the TA205 epitope resides.
If talin is involved in integrin activation, it follows that inte-
grin–talin interaction must be tightly regulated through inside-
out signaling. In other ERMproteins, an intramolecular associ-
ation of their FERM domains with the C-terminal tails masks
their functional binding sites for actin and adhesion receptors
[19,20]. Disruption of head–tail association in ERM proteins
is regulated by the binding of phosphatidylinositol 4,5-bisphos-
phate (PI(4,5)P2) or by PKC-mediated phosphorylation
[19,20,23]. Talin exists either as a globular monomer or an
anti-parallel homodimer [24,25]. In both structures, the talin
head and rod domains are likely in close contact with each other.
Nevertheless, direct interaction of the talin head and rod do-
mains has not been reported. In the present study, we demon-
strated that a talin rod fragment binds to the talin head (see
Fig. 6A), and we also observed that such interaction modulates
integrin binding to talin (manuscript in preparation). Consistent
with this notion, Yan et al. [26] reported that proteolysis of talin
with calpain, which separates its head and rod domains, in-
creases the binding aﬃnity of the integrinb3 tail to the talin head.
Finally, we found that TA205 inhibits talin head–rod inter-
action by approximately 30%, and conversely, the talin rod
fragment also causes similar inhibition of TA205 binding to
the talin head. These results suggest that TA205 binding to ta-
lin F1 also modulates the binding aﬃnity of the talin rod to the
talin head. In view that TA205 causes an allosteric inhibition
on integrin binding to the talin head, it is tempting to speculate
that such allosteric eﬀect also persists for talin head–rod inter-
action. However, at present, we cannot exclude the possibility
that the talin rod fragment binds close to the TA205 epitope in
talin F1, thus causing partial blockage of each other’s binding
to the talin head.
In sum, TA205 recognizes a species-speciﬁc epitope distinct
from the high aﬃnity integrin binding site in the talin FERM
domain, and yet it causes an allosteric inhibition of integrin–
talin binding and partially blocks talin head–rod interaction.
Thus, it represents a useful tool for examining the role of talin
in cellular function and the signaling mechanism regulating
integrin-talin interaction.
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